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3.1 Introduction
“How should we handle human embryos?” (the
early state of individual human development; an
egg that starts development because of
fertilization or nucleus transplantation), such a
new question of bioethics was raised in
association with the progress of life science
technology. Particularly, recent rapid progress of
life science technology has increased questions
and expanded the region, and this is reflected by
the situation in which guidelines notified by
government organizations increased suddenly
since 2001 (Table 1).
With such a background, at present when the
time limit for reviewing the law of human cloning
in 2004 is near at hand, how to handle human
embryos is being discussed repeatedly by Council
for Science and Technology Policy*1. Recently,
establishment of embryonic stem (ES) cells from
human embryo was started for regenerative
medicine, and researches using human embryos
have been increasingly demanded from the
medical aspects of conquering diseases and
disorders, and aging and dementia, as well as from
the industrial aspect*2. The handling criteria have
been decided not only in Japan but also in foreign
countries, respectively, and amendment to the
legal regulation was started with the change of the
status after the regulation (Figure 1). For example,
in Germany, where strict regulation on the use of
human embryos was provided by law in 1991, use
restr icted to imported ES cells came to be
permitted*3.
As for the actual situation in Japan, since the
first child born by in vitro fertilization (IVF) in
Japan in 1983, researches on assisted reproductive
– Law No. 104 dated July 16, 1997 (Latest amendment: Law No. 160 dated Dec. 22, 1999)
   “Organ Transplantation Law”
– Law No. 146 in 2000; December 2000
   “The law concerning regulation relating to human cloning techniques and other similar techniques”
– Notification No. 1 of the Ministry of Health, Labour and Welfare, the Ministry of Education, Culture, Sports, Science and 
Technology, and the Ministry of Economy, Trade and Industry in 2001; March 2001
   “ Ethical guidelines for research on human genome and gene analysis”
– Notification No. 155 of the Ministry of Education, Culture, Sports, Science and Technology in 2001; September 2001
   “The guidelines for derivation and utilization of human embryonic stem cells”
– Notification No. 173 of the Ministry of Education, Culture, Sports, Science and Technology in 2001; December 2001
   “The guidelines for handling of a specified embryo” (based on the law)
– Notification No. 5 of the Ministry of Education, Culture, Sports, Science and Technology in 2002; January 2002
   “The guidelines for recombinant DNA experiments”
– Notification No. 1 of the Ministry of Education, Culture, Sports, Science and Technology, and Ministry of Health, Labor and 
Welfare in 2002; March 2002
   “The guidelines for clinical research on gene therapy”
– Notification No. 2 of the Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health, Labour and 
Welfare in 2002; June 2002
   “Ethical guidelines for epidemiological research”
Table 1: Bioethics-related laws and government policies in Japan
medicine (reproductive medicine using ART for
sterility therapy) have been conducted, including
those associated with the preparation of embryos,
for more than 20 years under the self-imposed
regulation of the Japan Society of Obstetrics and
Gynecology. In assisted reproductive medicine,
there are surplus embryos (embryos fertilized in
vitro that have lost their purpose of use for
sterility therapy because a child was already born
or for other reasons), but these are disposed of.
On the other hand, as the restriction of ES cell
research in regenerative medicine and
embryology, creation of human embryos and use
of human embryos are restricted by government
policies, different regulations come to be applied
to a single type of biological specimens, and
ethical and social inconsistencies are indicated*4.
As stated above, in the process of the
development of current life science technology,
resolution of the bioethical issue became a subject
to be tackled by the society of each country as an
essential process. That is, it came to be recognized
that the practice of research activities was
inseparable from the social acceptance of the
researches*5. Such an inseparable relationship
between life science technology and bioethics
may be reflected in that the US allocates 3-5% of
the national expenditure on genome researches
for ethical, legal and social activities. Specifically,
from 1990 to 1999, in the US, 58 million dollars
(5%) from NIH and 18 million dollars (3%) from
the Department of Energy were appropriated,
resulting in the formation of an important
intellectual foundation of bioethics-related policies
(Ayano, 2001). The measures have raised the level
of the ethics review board, etc., and allowed
training of human resources to support them*6.
As known well from the birth of the first IVF
child in 1978*7 and preparation of the cloned
sheep in 1997*8, the UK (United Kingdom) leads
the world in the field of science technology. In
addition, as for social control of human embryos,
the UK has a unique social system with a history
of one decade, having “the law, and the control
organization designated by law” as the center of
activity.
On the other hand, in Japan, is there any
comprehensive social system that can act as a
basis to dynamically adapt to the bioethical issue
newly appearing and attempt to solve such issue?
In order to solve the bioethical issue that is likely
to become more serious in the future, under the
current status we should consider the necessity of
constructing a system (social governance system
of life science technology) to combine life science
technology and measures for social acceptance. At
that time, the existing system in the UK would
provide beneficial information to us. Therefore, I
shall introduce the background of the control
system of human embryos in the UK and the
practical functions. Table 2 shows a comparison
of regulations related to human embryos between
the UK and Japan.
3.2 System consisting of laws
and the control organization 
(see figure 2)
3.2.1  Traditional methods for deciding on
the law
The control system of human embryos in the
UK consists of the law and the special control
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 In the United States, the regulation and the virtual placement differ depending on the state.  The 
states belonging to (a) are (i) Maine, (ii) Massachusetts, (iii) Rhode Island, (iv) Pennsylvania, (v) 
Florida, (vi) Michigan, (vii) Minnesota, (viii) North Dakota, (ix) Louisiana, and (x) South Dakota 
(prohibition of researches and imports of ES cells).
The State of Iowa prohibits cloning only.  The states other than the above (i) to (x) virtually belong to 
(b).  Unlike other 49 states, the State of California is said to accept researches of human embryos in 
almost the same way as the UK, and accepts establishment of ES cells from cloned embryo.
Acceptance of establishment 
of ES cells from cloned 
embryo
UK, China, State of California 
in USA
Permission of use of embryos 
limited to surplus ones for 
establishment of ES cells
Japan, Korea, Russia*, Canada, 
Finland, Spain, Holland, Australia, 
(40 states* in USA (b))
Prohibition of establishment/ Per-
mission of use of existing ES cells
Germeny (Jul 2002 and after),
France* (May 2002 and after),
Denmark, (Subject study of 
the US federal budget)
Prohibition of establishment/ 
prohibition of use
Ireland, Norway, Switzerland, 
Poland, Italy*, Brazil,
(10 states in USA (a))
Permission of preparation of 
human embryo to establish 
ES cells, and permission of 
the use
UK, China,
(40 states* in USA (b))
Figure 1: Comparison of the criteria for establishment of ES cells using human embryos and the use of ES cells among
the countries (* shows a virtual placement)
Source: Walters’ data (2002) were modified, and some new information up to March 2003 was added.
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JapanUKCompared item
*: The law concerning regulation relating to human cloning techniques and other similar techniques
Law
(Human fertilisation and embryology act, 
etc., in 1990)
License system by the special control or-
ganization
(independent administrative committee)
Allowed.
Allowed.
Allowed.
Allowed.
Allowed.
Law
(Human reproductive cloning act in 2001) 
Prohibited.
Allowed. 
Prohibition of profit-making mediator’s 
business.
Allowed. 
Separate voluntary self-imposed controls 
by academic societies and the govern-
ment.
Separate review system by academic so-
cieties and the government.
Allowed in the society’s notice.
Allowed in the society’s notice.
Allowed for surplus embryos only by the 
government policy.
Prohibited by the government policy.
Allowed in the society’s notice.
Law
(Cloning law * in 2001) 
and the guideline based on the law
Prohibited.
Prohibited.
Prohibited (indirectly) in the society’s no-
tice; under consideration by the govern-
ment.
Under consideration.
• Form of regulation
 
• Control organization
• Assisted reproductive medicine (prep-
aration of in vitro fertilization embryo 
and transplant)
• Preparation of human embryo for re-
searches
• Establishment of ES cells
• Preparation of human embryo for es-
tablishment of ES cells
• Utilization of surplus embryos for re-
search
Comparison of cloning policies
•  Form of cloning regulation
•  Human reproductive cloning
• Therapeutic cloning (creation of cloned 
embryos) Prohibited.
Others
•  Surrogate mother
• Provision of embryo to other couple. 
Table 2: Comparison of policies regarding human embryos between the UK and Japan
Figure 2: Establishment of the social system for human embryos in the UK
VLA: Voluntary Licensing Authority for human in vitro fertilisation and embryology
ILA: Involuntary Licensing Authority for human in vitro fertilisation and embryology
HFEA: Human Fertilisation and Embryology Authority
HFEAct: Human Fertilisation and Embryology Act
organization designated by law (similar to an
independent administrative commission in Japan).
The method for deciding on bills used at the
establishment of the system in the UK, i.e., the
process for establishing a new social and legal
regulation, may be summarized as shown below.
(i) Consideration at the advisory committee and
publication of the report.
(ii) Presentation of the Green Paper (referred to
as the consultation paper; it states the
background of the problem, the points, and
choices of a solution to make an appeal to
society).
(iii) Presentation of the White Paper (framework
for legislation; proposal as a bill after
receiving responses to the Green Paper and
arranging for considered points).
(iv) Establishment of the law at the Parliament.
A series of the process for deciding on a bill
from causing the social disputes first to adopt the
responses is the general method that has been
conducted traditionally in the UK. The considera-
tion of the bill related to human embryo was
conducted through the same process.
3.2.2  Change of the control organization
The Report from the government inquiry into
human fertilisation and embryology (referred to as
the Warnock Report) in 1984*9. The Warnock
Report made recommendations concerning: (i)
licensing authority and its function; (ii) principles
related to the implementation; (iii) provision for
sterility therapy service; (iv) legal regulation of
related research; and (v) amendment to the
existing law regarding new science technology.
The most important point in the report is that it
stipulates a licensing organization designated by
law to socially manage (control) human embryo
research activities and assisted reproductive
medicine*10.
After the report, in 1985, the Medical Research
Council (MRC), a body promoting medical
research and related sciences, founded a voluntary
licensing authority (VLA) for human in vitro
fertilization (IVF) in collaboration with the Royal
College of Obstetrician & Gynecologist (RCOG),
which coordinates obstetricians and gynecologists
in the UK, thereby establishing the fundamental
skeleton of the current control organization’s
function and system.
As a background to the establishment of VLA, it
was reported that a situation had developed
because the government had not dealt with this
matter immediately, and that there were circum-
stances in which control based on standards was
required to avoid lawsuits from a clinical position
when conducting sterility therapy. VLA was based
on the recommendations of the Warnock Report,
which required: (i) deciding on the code of
practice; (ii) licensing of human embryo research
and assisted reproductive medicine; (iii) grant
review; (iv) reporting to MRC/RCOG; (v)
disclosure of information related to the practice;
and (vi) contributions to measures for social
arguments and control procedures. Therefore, the
current function of the control organization
already included a major part of the recommenda-
tions. The VLA published reports annually in an
effort to disclosure information.
However, by the nature of VLA, individual
licensing and code of practice were dependent on
voluntary participation, and its social position was
different from the current Human Fertilisation and
Embryology Authority (HFEA) mentioned later,
which is an independent, national control
organization with a compelling force.
The VLA changed its name to the involuntary
licensing authority (ILA) for human in vitro
fertilisation and embryology in 1989. To deal with
the circumstance in which the RCOG stopped
financial support due to monetary difficulties and
the remaining MRC began receiving government
allocated assistance, the VLA, in an effort to urge
the government to act, emphasized through its
name that the VLA was a tentative organization
until the government formed a statutory organiza-
tion.
With such a background, through the establish-
ment of the Human Fertilisation and Embryology
Act (HFEAct) in 1990, the control organization
HFEA was founded and started activities in August
1991.
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3.3 Establishment of HFEAct
for the handling of human 
embryo and the following 
movements
3.3.1  From the Warnock Report to today
After the Warnock Report was published in
1984, individual views and reports on the subject
of human embryo were announced by specialists’
groups such as British Medical Association, RCOG
and MRC, and religious groups such as the Roman
Catholic Church, and researchers reportedly
conducted a campaign*11. Taking this opportunity,
the government caused arguments by the green
paper in 1986, and after receiving the responses,
they asked people’s opinions by presenting a
framework of legislation in the white paper in
1987, and a law was established at the Parliament
in 1990. The skeleton of the established law,
HFEAct, is (1) regulations of prohibited matters
and punishment, and (2) establishment of a special
control organization and regulations on the
function.
At the time point of the establishment of
HFEAct, the systematic foundation related to the
handling of human embryo was prepared.
However, science technology always continues to
progress. After the establishment of the law,
researches in the fields of regenerative medicine
and gene therapy progressed remarkably, and in
1998, recommendations (Human Genetics
Advisory Commission and HFEA) were made
considering the progress during this. In 1999, a
committee was organized under the Chief Medical
Officer, and a recommendation regarding mea-
sures to deal with the change of science tech-
nology was made. Based on the recommendation,
in 2001, Human Fertilisation and Embryology
(Research Purpose) Regulations were established
to add (i) increasing knowledge about the
development of embryos, (ii) increasing knowl-
edge about serious diseases, or (iii) enabling any
such knowledge to be applied in developing
treatments for serious diseases. In the same year,
the Human Reproductive Cloning Act 2001 was
established to prohibit the preparation of
reproductive cloning that produces human cloned
individuals (therapeutic cloning: preparation of
cloned embryos was non prohibited) and provid-
ed for punishments.
With the expansion of the use of embryos for
research purpose, there was a new movement. For
human fertilized embryo and cloned embryo, the
House of Lords select committee that conducted a
positive verification regarding the actual status of
use for researches compiled a report on stem cell
research in February 2002. The report refers to 27
items including continuation of the use of human
embryo and cloned embryo within 14 days, and
the idea of setting up a stem cell bank*12.
Complying with the recommendation, the
Department of Health published a report on the
measures to deal with this in July 2002. The report
gives a conclusion almost in accordance with the
House of Lords select committee report, and the
department had conducted individual investi-
gations of the items shown by the committee and
gave their opinion on measures to deal with them
in the report.
3.3.2  Current status of regulation
As the general situation of human embryos in
the UK, the permit (license) system for
preparation and use of human embryos and
prohibition of the use after appearance of the
primitive streak may be given*13. The prohibited
matters related to human embryos in the UK are:
first of all, (1) creation, storage and use of human
embryos are prohibited except for creation or use
under permit (license). (2) What can be trans-
planted to humans should be a human embryo or
gamete (sperm and egg), and the use after
appearance of a primitive streak is prohibited. The
primitive streak, which is the first characteristic
change observed in the embryo, is formed when
the embryonic end in one direction is raised on
the 14th or 15th day after fertilization. The
separation of uniovular twin occurs until this time
at latest. Based on the primitive streak, a
medullary groove is formed up to 17th day, and up
to around 23rd day, the bilateral structure referred
to as neural folds is fused, and “spinal cord (neural
tube)” comes to be observed. At the same time, in
the law, from a practical point of view, the
corresponding time (to use human embryos for
research) is provided as “embryo not later than the
end of the period of 14 days” (after gametes are
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mixed).As prohibited matters, transplant of human
embryo to animals is prohibited, and nucleus
transplant to embryo is prohibited. In addition, for
gametes, (3) it is prohibited to conduct the storage
of gametes, artificial insemination, and cross-
fertilization with animals without permission.
The ES cells are often established 4–5 days after
fertilization, and, as such, are not prohibited.
Preparation of human embryos and cloned
embryos for research purpose is permitted, but
preparation of cloned individuals is prohibited. For
the prohibited matters, punishments are imposed,
and imprisonment for a term not exceeding 10
years or a fine or both, are imposed.
On the other hand, in Japan, preparation of
cloned embryos is prohibited by the law
(“guideline for handling of specific embryos”
based on it), and for creation of human embryos
for research purpose, there are different opinions
in the arguments.
3.4 Public control organization
HFEA
HFEA is a public organization under the control
of the Department of Health, and one of the
characteristics is its high independence secured.
The function and the placement in the
administrative organization are regarded to be
corresponding to the independent administrative
committee in Japan (administrative committee
with independence based on Article 3 of the
National Government Organization Law). That is,
HFEA is (usually) placed as an extra-ministerial
department of the department, and an adminis-
trative organization that functions independently.
For example, the Japan Fair Trade Commission of
the Ministry of Public Management, Home Affairs,
Posts and Telecommunications corresponds to
this.
3.4.1  Summary of functions
Major functions are as shown below.
(1) Granting a license to institutions conducting
the assisted reproductive medicine and
human embryo research, and inspections.
(2) To produce a Code of Practice.
(3) Control of storage of gametes.
(4) To keep a formal register of information
related to the practice.
(5) Publicity work and information supply
activity.
(6) Assistance in deciding on administrative
measures, etc.
3.4.2  Composition
Twenty-one committee members including the
chair, and 4 senior staff and 1 observer from the
Department of Health share the duties of 7
departments (committees and work sections) with
the respective functions. The committees of HFEA
include (i) Audit Committee, (ii) Code of Practice
Committee, and (iii) Licensing & Fees Committee,
etc., and they work independently, respectively. To
the persons including the committee members,
other research staffs are added, and the total
number of the personnel in the HFEA’s Executive
is 45. The scale of budget for fiscal 2001 was
about 2,880,000 pounds (about 550,000,000 yen).
One half of this is covered by the license fees, and
the other half is covered by the budget of the
Department of Health. The expenditure included
human expenses 1,360,000 pounds and opera-
tional expenses 1,310,000 pounds, etc.
3.4.3  License
As of 2002, 115 institutions were registered
centering on institutions practicing the assisted
reproductive medicine. The institutions practicing
in vitro fertilization (IVF) were 75 institutions, and
those practicing only artificial insemination were
23, and those practicing only researches were 6.
The annual number of IVF practiced was 25,273
cycles, and there were 5,513 births.
The license system is associated with the
obligation of detailed reporting and the inspection
system. In the license system, some clinics are
judged as unlicensed, or occasionally the license
may be revoked. Therefore, for the practice of
assisted reproductive medicine, occasionally there
are some cases of lawsuits due to the license, and
due to the supervising right of HFEA regarding
whether it is appropriate or not to practice the
assisted medicine. Of unlicensed clinics or clinics
whose license in the UK was revoked, some were
reported to have moved, for example, to the US to
start practice. In such a sense, the technical level
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as clinics has been maintained in the UK
considering patients first. As for the number of
revocations, two were reported in the first 9 years
(Brinsden, 2000).
Based on data information obtained from
practicing institutions, a guidebook for patients
who receive the assisted reproductive medicine,
The Patients’ Guide to IVF Clinics Provisional Data
2002 presenting detailed and specific up-to-date
data in each medical institution was prepared to
provide data. The therapeutic results and the
number of patients are easily available from this.
As stated above, HFEA is securing the quality
level of human embryo-related medical care and
research through the license system and the
information supply to patients.
Meanwhile, a research subject applied to HFEA
is submitted after being reviewed first by an
institution outside of the institutions conducting
the research, an ethics committee (for example, a
public ethics committee LREC: the UK has an
independent system of ethics review and advisory
organization called Research Ethics Committees
(REC) under the control of NHS of the
Department of Health. In the system, LREC is the
organization located for each area.). At the HFEA,
after the research subject is reviewed by
specialists, it is reviewed at the committee
meeting*14. Since 1991, of 141 subjects submitted,
136 subjects were permitted, and 77 of them were
already completed. As of August 2002, 28 research
subjects were being conducted at 19 institutions.
Major contents of the subjects are related to the
assisted reproductive medicine. As for ES cells,
from human embryo to the establishment of the
cells is a scope supervised by HFEA, but the
supervision is not extended to the use of the cells
after they are established once. At present, a stem
cell bank is being planned by MRC. In 2002, two
plans of ES cell establishment were permitted.
The reference data on the actual use of embryos
are shown below.
Reference data:
Statistics on the use of human embryos from the UK
between 1991 and 1999 (Walters, 2002).
(The data are based on the HFEA annual report
and the House of Lords select committee report on
stem cell research.)
3.4.4  Inspection
In the inspection of a practicing institution, an
inspection team is usually chaired by an HFEA
member and includes a clinician, a scientist, a
person with a background in another field (such
as counselling or nursing) and a member of the
HFEA’s executive staff. The main activity of the
inspection team is to visit the institution
unannounced. To organize such a team, HFEA
currently employs 52 part-time inspectors. An
inspection protocol for the inspecting procedures
was prepared and being used with occasional
revisions as needed. Such a practical inspection
was not the first one in the UK, and in the
investigation of experimental animals conducted
from a viewpoint of protection of animals from
harm under the control of the Home Office, the
same method was used, i.e., investigators inspect-
ed the institution without prior notice.
3.4.5  Renewal of the license
The license had been renewed every year
before, but at present, for institutions with
achievements, it was changed to be renewed every
3 years. In addition to the conventional inspective
investigation conducted every 3 years for the
license review, a small investigation referred to as
an interim inspection is conducted for important
items only based on the previous investigation (by
the same method as that in the main investi-
gation).
3.4.6  Code of Practice
HFEA produces the required code of practice
(i) No. of embryos created: 925,747
(ii) No. of embryos transferred: 423,153
(iii)No. of embryos stored for own treatment: 225,627
(iv)No. of embryos stored for treatment of others: 448
(v) No. of embryos given to research: 53,497
(vi)No. of embryos discarded : 294,584
(vii)No. of embryos created for research purposes: 118
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based on the HFEAct, which provides guidance for
clinicians and researchers on the practical
procedures in carrying out their licensed
activities. What is regarded as particularly
important in the basic concept of the code of
practice is the role to protect the “welfare of a
child who may be born.” The code of practice
provides for; (i) guidance on the proper conduct
of activities of those who are licensed, (ii)
standards for the materials and facilities, (iii)
welfare of the child, (iv) selection and screening of
donors, (v) confidentiality, (vi) provision of
information, (vii) consent, (viii) offering of
counseling, (ix) use of gametes and embryos, (x)
storage and handling of gametes and embryos, (xi)
standards and prohibitions in researches, (xii)
records, and (xiii) filing of complaints,
respectively.
The code of practice is decided on by HFEA, and
goes into effect with the approval of the
concerned secretary of state. The currently used
one is the fifth edition, and the sixth one will be
issued within the year 2003.
3.4.7  Pursuit of transparency
HFEA is always making an effort to increase the
transparency to the society. Particularly, the
thorough publicity work on the status of activities
and the status of finance, and information
obtained in the control is attempted. This is
indicated in the reports consisting of detailed and
specific descriptions (HFEA, Eleventh Annual
Report and Accounts 2002).
3.4.8  Maintenance of independence
HFEA requires approval of the Secretary of State
for the code of practice, and has an obligation to
report to the Secretary of State. However, in the
function, deliberations and decision, HFEA is said
to be keeping the independence from the
Department of Health and specialists’ groups such
as RCOG. The relationship between the Depart-
ment of Health and HFEA is said to be a good
“liaison” relationship, in which both always
contact each other and work in close cooperation
with each other. However, in the aspect of bud-
gets, it was reported that there was friction
between both.
3.4.9  Recruitment of committee members by
public advertisements
The employment of committee members and
staff of the HFEA including the chair was
conducted through public advertisements, and it
was announced that the equal opportunity was
respected with elimination of every discrimination
and prejudice. The applicants were recruited for
the posts by public advertisements on the
newspaper, etc., and selected through an inter-
view by 3 persons, i.e., the chair of HFEA, one of
the HFEA members, and a person in charge from
the Department of Health. For example, there
were 339 applicants for posts of 4 members, and
this indicates the high level of social interest and
appreciation of the duties of HFEA.
3.4.10  Specialists and general citizens
Without cooperation of specialists, it is
impossible to understand and grasp professional
matters appropriately, and without participation of
general citizens, the social self-decision cannot be
established. In the resolution of bioethical issue,
mutual cooperation of specialists and general
citizens is considered to be essential.
At the HFEA, the chair and the vice-chair require
to be non-specialists (not a clinician, a person
engaged in assisted reproductive medicine, or a
researcher to obtain the grant), and the percentage
of specialists in the committee was prescribed to
be controlled as one third to one half of that of
non-specialists. Besides, the members including
the chair are recruited by public advertisements as
shown above.
In the process of deciding on the code of
practice and implementation of the inspection, the
specialists are essential. However, the main axis of
HFEA is not only to have specialists’ assistance and
criteria of technological judgement but also to
have a viewpoint to embody the social judgement
taking into account the general citizens’ opinion
and standpoint. This may have made it possible
that the control system in the UK achieved the
social trust.
3.4.11  Evaluation of HFEA
According to the comprehensive evaluation of
HFEA by people concerned, the HFEA is working
very effectively, though not completely. In such a
circumstance, it is obvious that researches should
be conducted in a situation that science and
technology are socially accepted (social persua-
sion and social self-decision), and researchers who
are controlled understand that understand the
necessity of procedures associated with this.
Particularly, for researches using the national
budget, the above is recognized as natural in the
relationship with taxpayers.
However, on the other hand, HFEA is exposed to
social indictment. For example, there was a
medical mistake at a clinic where a black child
was born to a white couple due to transplantation
of a wrong embryo by mistake, and the HFEA was
called to account for the medical mistake. As
another recent example, when a couple having a
child with a genetic blood disease called tha-
lassemia were expecting their second child, they
received a pre-implantation genetic test to select
an embryo, and as a result, a healthy child was
born. In addition, the couple planned to use the
newborn’s cord blood for treatment of their first
child. The HFEA approved the plan, but a Catholic
pressure group named Comment on Reproductive
Ethics (CORE) indicted HFEA for the approval. As
a result of the struggle in the courts, HFEA lost the
suit, and the plan was prohibited (BBC News
World Edition on Dec. 20, 2002).
3.5 Background of establishment 
of human embryo control 
system in the UK
At present, in the UK, it is said difficult to grasp
the cultural and religious background as a
stereotype (increased religious diversity,
bipolarization of the educational level, high or
low). However, in the agreement of social
regulations, it is possible to indicate the presence
of strict pragmatism as shown below.
(1) Stance related to the formation of social
arguments 
It is not realistic to expect that all of the general
public should have a deep knowledge and interest
in the issue disputed and the point. However, it is
important to release information at least to
interested people to hear their opinion thor-
oughly, and give them opportunities to have a
discussion, and a mechanism to secure the
transparency in the implementation of the system
should be created.
(2) Stance related to ethics and social
regulations
In the society of liberalism, the existence of the
individual personal ethical sense is allowed. Then,
in any agreement of social regulations, complete
ethical agreement is difficult. Therefore, the major
premise made is that it is natural that there is a
certain degree of gap between the personal
ethical sense and the social regulation and control
system. On the premise, an ethical discussion is
made to minimize the sum of the social gap. In
addition, from the premise, measures to set up a
very effective control system and secure the
transparency in the system and realize partici-
pation of citizens may be adopted.
(3) Stance to the uncertainty of science
technology
It is considered inevitable that the uncertainty
(possibility of an unexpectable risk) exists in
application of new science technology. Therefore,
it is always demanded to make a judgement and a
self-decision always weighing the risk and benefit
ratio, and it is considered important for the society
to make a situation in which such a self-decision is
possible (a discussion on the degree of the
uncertainty and a discussion to clarify it are not
made throughout to the end).
In the background of the system in the UK,
there may be a formation of social structure that
can realize the consciousness of r ights and
methodology rooted in the pragmatism, while it is
a society of individualism and liberalism with a
long tradition. In the UK, to meet the social
demand, the human embryo-related control
system can immediately stop the research without
adding a new legal regulation, as authority of the
control organization (HFEA can immediately
suspend the license based on a reasonable
ground). In that sense, the system in the UK may
be said to be a system possible to take quick and
f lexible measures to meet social demands,
differing from the US without federal legal
regulations on the assisted reproductive medicine
and general researches of human embryo and
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Japan only depending on self-imposed regulations
on them. Needless to say the foundation of such
quick and f lexible measures exists in the
comprehensive function of the control system in
the UK including the inspection that can grasp the
actual status of the implementation of human
embryo research and assisted reproductive
medicine. With the uncertainly contained, such a
system possible to take f lexible measures is
considered to be important as a foundation or
background to appropriately implement and
develop the life science technology attempting
the social acceptance as well.
As opportunity to have a direct discussion
between the general society and proposers of the
measures, a sex selection debate was held, and
here we introduce the discussion as one sample of
the discussion between them.
First, HFEA published a booklet (called a
consultation document) compiled to cause
disputes in the general society. Making this a
common basis, a few dozen of general participants
who got together in a corner (Jubilee Room) of
the House of Commons and several panelists of
specialists including the chair of HFEA had a
discussion to directly talk with each other. In the
discussion, there were some participants from the
pressure group opposed to the HFEA, and
occasionally a considerably hot discussion was
made. After the discussion, the participants had an
informal talk over light meals at the site, and
interested persons had a discussion with each
other.
In the issue of sex selection, the main point is
whether its general application is approved or not
besides medical reasons. In addition to various
social issues related to sex differences, whether it
is right or wrong that the acceptance of sex
selection may lead to selection or preparation of
born children with characters that the parents
want by the genetic diagnosis or modification (as
the door to a designer baby) is being discussed.
As stated above, in the relationship with the
general society, (i) information supply from the
professional organization, (ii) direct exchange of
opinions and discussions, and (iii) mutual
understanding through them and adopting
opinions from the general society are conducted.
We can say that the discussion between the
general citizens and specialists is an example
contributing to the formation of the basis of
mutual understanding (sharing of information and
knowledge) when the control organization and
the general society solve a problem collabora-
tively.
3.6 Conclusion–Consideration of
a system construction
in Japan
It is possible to grasp the elements of the system
in the UK, based on their interrelationship as
shown in Figure 3.
Firstly, in this system, the organization set up by
law decides on the code of practice from a
professional point of view. The code of practice
itself has no binding force associated with
punishments. However, at the licensing, the status
of the practice is evaluated from the viewpoint of
the code of practice, and if there is any
inappropriate deviation, the license is revoked.
Conversely, when the status related to the practice
changed with the progress of life science
technology, even if it is a method not necessarily
meeting the code of practice, if its validity was
confirmed, the method can be approved by
judgement of the committee.
That is, for the code of practice showing
practical procedures, if more developing method
was established with the progress of life science
technology, the new method can be adopted
without adopting the code. The validity is judged
by the committee at the licensing, and if the new
method was appropriate, it will possibly be
approved. Unlike law, the code of practice can be
revised by the committee permanently set up in
the control organization, and it is easy to take
appropriate measures at the present time
including the social acceptance. That is, the
flexibility and adaptability to deal with a new
problem, which are important characteristics of
the system in the UK, are based on the functional
liaison between the licensing organization and the
code of practice decided on by the licensing
organization. An important function to support
the evaluation in such a licensing is considered to
be the inspective investigation, and the function is
conducted by the method that becomes effective
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by the control organization.
Secondly, the important point is to be careful
about securing the independence and trans-
parency of the professional control organization,
and to conduct deliberations of the licensing by a
committee meeting established by participation of
both general citizens and specialists. As a result,
the committee can make a judgement from a
viewpoint of the general society, and it becomes
possible to avoid the separation of the judgement
at the control organization from the social
acceptance, and it may lead to that the social trust
of the control organization can be obtained.
Thirdly, the professional control organization
has an investigation and research functions. The
function makes appropriate advice related to
measures, and information supply and publicity
work possible. That is, it makes it possible to share
the information to be a basis of judgement at the
committee of the control organization and
information to decide on the related bill among
the people concerned, specialists and the general
society. In other words, appropriate information
can be supplied not only to the committee of the
control organization but also to the social
discussion and the discussion at the site of
deciding policies. The review (for example,
consultation document on a specific problem)
issued by the UK’s control organization HFEA has
very high quality contents. The high level of the
control organization that can issue such a review
can increase the reliability in the general society,
and is presumed to be reflected to the high level
of measures. Besides, with the accumulation of
information at the professional control organi-
zation, that it is possible to develop the ability of
the investigative research function itself more
getting new information continuously may be
important as a basis to deal with the development
of life science technology in the future.
In addition to the construction of such a system,
the organization to practice and researchers
should understand the significance of social
acceptance in the progress of science technology
and accept the social control system. It is
expected that specialists’ groups do not remain in
their private position and are involved in public
measures voluntarily, and it is also expected that
members of the general society are positively
involved in the formation of public measures as
formers of a community, and it is important that
the opportunity and process for discussions and
hearing for that are set up.
As for the uncertainty contained in the state-of-
the-art life science technology, as the research
develops, the actual status and the practical
influence become visible. Besides, new science
technology appears one after another. Then, a
static regulation only by law has its limitation. On
the aspect of life science technology changing all
the time, and on the aspect of the society that
accepts it, a dynamic and comprehensive control
Figure 3: Analysis of the system structure in the UK
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system works to deal with them appropriately, and
the development of life science technology and
the social acceptance must be obtained at the
same time. The system in the UK is considered to
be clearly suggesting what kind of social
governance system is required in Japan.
How the respective countries deal with
common social questions (ethical questions of
science technology) raised by life science
technology developing rapidly will have a
significant inf luence on the future world.
However, as seen in the questions raised by the
state of the social regulation of bioethical issues, at
present in Japan, (i) we can say that the social
technology forming the social system to adapt to
changes and the basic structure to give dynamism
to various systems constituting the society are still
poor or fragile. In addition, (ii) we can indicate
that the system to realize and operate the
community to flexibly adopt the social voluntary
participation and social opinions and discussions
is not enough partly. Therefore, the general
citizens, specialists’ groups and government must
collaboratively aim to realize the practice of
researches and medical care and the social
acceptance at the same time.
In the future, the bioethical issues induced by
the progress of life science technology are
considered to be increased and more serious, and
to resolve them, it may be the time for Japan to
aim at constructing a social governance system
(control system based on the social self-decision)
of life science technology. When we construct a
system that conforms to Japan, it is effective to
refer to the state of the existing system in the UK
constructed reasonably. That is, what we have to
consider is setting up an independent committee
that controls bioethical issues, and constructing an
organization to solve problems professionally
based on the licensing system, and the system.
With such a system as a skeleton, the basis to
deepen the arguments of bioethical issues in the
society and the basis of the transparency and
disclosure are likely to be formed.
In the US where there is no professional control
organization established similarly to Japan, there
was an opinion that the necessity of setting up a
professional control organization for the current
life science technology was the same as the
necessity of setting up the Federal Aviation
Administration to deal with the civil aviation
services that had just appeared. This indicates that
the new aspect of the modern life science
technology is already in a situation difficult to
control as science technology of new age without
a professional organization (Fukuyama, 2002).
For Japan aiming at a nation based on science
technology and invention, the touchstone for
future prospects of science technology and social
system in Japan may be unexpectedly found in
such a point (how to tackle the construction of a
social system to deal with the bioethical issues).
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Glossary
* 1 The clone law and arguments at the Council
for Science and Technology Policy (Expert
Panel on Bioethics)
The clone law, “The Law Concerning
Regulation Relating to Human Cloning
Techniques and Other Similar Techniques”
(2000), was provided mainly to prohibit
preparation of human cloned individuals.
Article 2 of the supplementary provisions
provides “within three years of this Law, take
necessary measures in accordance with the
results of the study and examination by the
Council for Science and Technology Policy,
Cabinet Office concerning the method of
handling of a human fertilized embryo as the
beginning of a human life” and the time limit
is June 2004.
The assisted reproductive medicine is being
conducted in at least 36 countries as sterility
therapy (Suganuma, 2001; pp. 152-161), and
the criteria provided individually are used in
the respective countries. However, a standard-
ized regulation is being sought out by EU
(European Group on Ethics in Science and
New Technology).
* 2 Regenerative medicine and ES cells
“Regenerative medicine” is to positively utilize
cells of biological tissues or organs that
caused functional disorder or dysfunction to
attempt regeneration of the functions (The
Japanese Society for Regenerative Medicine).
As cells expected to support such a medicine,
cells having proliferative ability (and
autoproductivity) and differentiating ability,
that is, cells called stem cells attract attention.
The stem cells consist of embryonic stem (ES)
cells established from early embryo, fetal
tissue stem cells and EG cells established from
fetal germ tissues, and somatic stem cells
possible to be collected from adults. In
relation to human embryos, particularly,
establishment of ES cells is the question.
The property of ES cells is that they have a
latent ability that may contribute to formation
of every organ, and that they have a good
proliferative ability and a great deal of
experience in animal experiments and are
considered to be easy to establish a culture
system maintaining the character stably. As for
somatic stem cells, one type with a good
differentiating ability was reported, but the
difficulty in their collection and growth in the
culture system is indicated.
* 3 Change of the regulation of human embryo
In Germany, “the law of embryo protection”
was established in 1991, and the use of
human embryos was str ictly restr icted,
although the assisted reproductive medicine
was allowed. However, according to “the stem
cell law” (Gesetz zur Sicherstellung des
Embryonenschutz im Zusammenhang mit
Einfur und Verwendung menschlicher
embryonaler Stamzellen) proclaimed on June
28, 2002 (enforced on July 1), as an
exceptional provision, the import and use of
ES cells for researches were to be allowed
conditionally (Iwashi, 2002). In the UK, in
2001, the text of the law was added to
approve expansion of the use for researches.
* 4 Regulation in Japan and the issues
In our country to date, no law including
comprehensive and direct provisions on the
handling of human embryos has been
established. The Japan Society of Obstetrics
and Gynecology has established rules as the
society’s notice to apply them to the assisted
reproductive medicine and researches
conducted by the members. However, it is in
a state of voluntary and arbitrary one limited
to the members registered at the society.
On the other hand, there are various issues
including the current status that occasional
acts contrary to the self-imposed restraint of
the society’s notice are performed openly,
appearance of the new concept of giving
priority to children’s welfare such as the right
to know their birth details and parentage,
demands of mental support by counseling,
and complicated genetic and social mother-
and-child relationship related to surrogate
mother, embryo provision, and artificial
insemination and concern about the
inf luence on the legal system and social
system. With the question about whether the
assisted reproductive medicine between non-
spouses is right or wrong including all the
above issues, discussions considering the
legislation are being conducted centering in
an investigational committee at the Ministry
of Health, Labour and Welfare (Assisted
Reproductive Medicine Section, Health and
Science Council). However, the assisted
reproductive medicine between spouses
remains to be left without particular control,
regulation and protection of the government.
* 5 Progress of life science technology and
bioethics
In March 2001, in the “Science and
Technology Basic Plan” for the second term,
life science was given as one of four fields
regarded as important, and in the item of
“Science technology-related ethics and social
responsibility,” the significance of the issue of
bioethics as a subject inseparable from the
development of science technology was listed
first.
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* 6 Sociological consideration as part of life
science technology
In the US, research programs of Ethical, Legal
and Social Issues (ELSI) were started in 1990.
The purpose is to specify the ethical, legal and
social issues associated with the human
genome plan and genome researches, and
analyze them, and provide information about
the issues to the general society.The research
programs are used by the National Human
Genome Research Institute (NHGRI) of NIH
and the Office of Biological and Environ-
mental Research (OBER) of the Department of
Energy. By the authorities, at least 284
research and education programs were
supported, and more than 625 achievements
were reportedly made. The achievements
were evaluated to be an important intellectual
foundation of bioethics-related policies. EU
appropriate 2% of the budget of science
research grant-in-aid for ethical researches
(Ayano, 2001). The Japan Association of
Bioindustries Executives, 2001.
* 7 In vitro fertilization (IVF) children
Patric Steptoe and Robert Edwards, whose
study succeeded in the birth of the first IVF
child, reportedly could not get public research
expenses because of doubts in safety (J.
Gunning).
In Japan, the birth of the first IVF child was
reported by Tohoku University in 1983, and
ethical disputes were caused, and at the same
time, many inquiries from people suffering
from sterility were reportedly received at the
Department of Obstetrics and Gynecology of
the university (Suganuma, 2001, as citation
from Suzuki, M.: “In Vitro Fertilization:
Documentary to the success,” Kyoritsu
Shuppan, 1983).
In Japan, there were reportedly 12 thousand
cases of IVF children (approx. 1% of all
newborns, 2000) annually, and more than 40
thousand cases in cumulative total (Council
for Science and Technology Policy, 2001;
Suganuma, 2001, pp. 72–82).
* 8 Human cloning
Currently, international cooperation of human
cloning regulation, that is, an international
treaty for prohibition of human cloning is
being assessed in the United Nations
(proposed by Germany and France at the 56th
general assembly on August 7, 2001).
However, some countries are appealing for
prohibition of both reproductive cloning and
therapeutic cloning centering in the US, and
other countries are appealing for prohibition
of reproductive cloning first of all (e.g.,
Germany, France, Japan), and the difference in
opinions between both has not necessarily
been ironed out (Hishiyama, 2002).
* 9 Details leading to the Warnock Report and
HFEAct
For the details leading to the Warnock Report
and HFEAct, Miki (1995) analyzed them as
shown below.
The Departmental committee on Human
Artificial Insemination, which was set up
within the government office in 1958, issued
a report in 1960. In the report, they approved
artificial insemination with husband (AIH),
and stated that they did not regulate artificial
insemination with donor (AID) but would not
use it as far as possible. After that, in 1973, a
committee set up in the British Medical
Association made a proposal, and based on
the proposal, the self-imposed restraint by the
Royal College of Obstetrician & Gynecologist
(RCOG), establishment of the AID center, and
application of the National Health Service
were realized. At this point of time, artificial
insemination is considered to have been
accepted as a technique socially insuppressi-
ble.
* 10 Warnock Report
The Warnock committee was organized as an
advisory committee by the government in
1982.
• The composition of the members is:
philosophy 1, theology 1, administration 1,
midwife 1, clinician 3, psychology 2, medical
research 1, head of review board 1, social
worker 1, lawyer 2, foster parent association 1,
chairman of foundation 1, a total of 16
members.
• Collection of opinions: testimonies of 254
groups, 695 letters remitted.
• Subjects discussed: (a) common issues, (b)
individual issues ((i)artificial insemination, (ii)
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in vitro fertilization, (iii) offer of egg, (iv)
offering method of embryo, (v) surrogate
mother, (vi) application of the technique of
sterility therapy, (vii) freezing and storage of
semen, egg, and embryo), (c) research of
various problems in scientific research and
the prospects, (d) contraceptive treatment
service and regulation of research.
• The composition of each subject was to be:
(1) definitions and contents, (2) objections,
(3) favorable opinions, (4) view as the
advisory committee and the matters to be
noted.
• As for the conversion of opinions, it
conversed in all items except for the item of
use of embryo. Issues with different opinions
were described at the end of the article as
“expression of different opinions.”
* 11 Social responses after Warnock Report
Many mass media took up the report in the
society, and in 1985, it was reportedly agreed
that the issue is a social problem requiring a
careful consideration (Muto, 1994). As a result
of a sufficient campaign, general people’s
interest was caused, and the human embryo-
related knowledge, for example, even what
“the primitive streak” was said to have spread
in those days (A. McLaren).
In the health system in the UK, the order of
priority in the fund supply of the National
Health Service (NHS) by disease is decided by
the local authorities, but the order of priority
in assisted reproductive medicine is not high
(said to be after treatment for erasing tattoos).
The fund is only received for about 20% of the
assisted reproductive medicine, and there are
some conditions in the fund supply, and it is
reported that there is a waiting list of about 4
years (Ishii, 2001b).
* 12 House of Lords select committee on stem
cell research report
Considering the expansion of researches
using embryo in 2001, a positive investigation
of the actual use for research purpose was
conducted to report. For the investigation,
testimonies were obtained from 53
associations and 58 persons in writing or in
writing and orally, respectively, to make them
grounds for judgement.
The principal points of the investigation
were: (i) the point that use of embryo may be
unnecessary because of the progress of
somatic stem cell researches, (ii) the point
that use of embryo is expanded to the
research purpose may be ethically
inappropriate, and (iii) the point that the use
may lead to preparation of cloned individuals.
For these points, recommendations covering
27 items were made, and a summary or copy
of the major items is shown below. (The
figures are the numbers specified in the
report.)
4. To ensure maximum medical benefits, it is
at present necessary to keep open both
routes (ES cells and somatic stem cells) in
therapy, since neither alone is likely to
meet all therapeutic needs.
7. Whilst respecting the deeply held views of
those who regard any research involving
the destruction of a human embryo as
wrong and having carefully weighed the
ethical arguments, the Committee is not
persuaded, especially in the context of the
current law and social attitudes, that all
research on early human embryos should
be prohibited.
8. Fourteen days should remain the limit for
research on early embryos.
9. Embryos should not be created specifi-
cally for research purposes, unless there is
a demonstrable and exceptional need that
cannot be met by the use of surplus
embryos.
11. With regard to the rule of embryos for
research purposes within 14 days, ethical-
ly, fertilized embryos are not distinguished
from cloned embryos.
12. Cloned embryos should not be prepared
unless there is sufficient reason that
surplus embryos are inappropriate for a
specific purpose.
14. Due to the problem of safety, preparation
of human cloned individuals cannot be
approved at this stage.
15. From an ethical point of view and due to
problems involving human experiments
and the welfare of the family and children,
etc., preparation of human cloned indi-
viduals cannot be permitted.
19. In light of the progress of somatic stem
cell researches, etc., whether human
embryo researches are still required or not
should be judged at an appropriate time,
perhaps towards the end of the decade.
23. When the Government brings forward
legislation, consideration should be given
to making an express provision for such
basic research when necessary as a
precursor for the development of cell-
based therapies.
24. The condition of offering sperm and egg
free of charge is important for preventing
commercialization of assisted reproduc-
tive medicine, and should be strictly
maintained.
26. It is necessary to establish a stem cell
bank under a committee for supervision
and direction in order to verify the quality
of ES cells and to monitor the use, and the
ES cells for research licensed by HFEA
should be registered there.
27. Considering well the characteristics of ES
cells that enable permanent subculture,
HFEA should make it mandatory to obtain
informed consent for such use including
for various situations in the future. If the
range of use is limited in the first informed
consent, ES cells should not be established
using an embryo.
* 13 Primitive streak
Since Warnock Report, in the UK, based on
the developmental change, the appearance of
“primitive streak” has been used as an aim of
one section in the development from embryo
to individual.
Reference:
In Germany, the process after fertilisation to
the time point of nuclear fusion is not
regarded as a human embryo to be protected.
It is because after fertilization, two pronuclei
originated from the sperm and egg,
respectively, exist separately for about 12-24
hours to cause DNA replication, and after
completion of the replication, nuclear
membrane is fused and synapses of
chromosomes occur first, when the maturity
as a single cell is completed. During the time,
it is a stage on the way to formation of a single
embryo possible to grow, that is, it was
regarded as not corresponding to the concept
leading to a human individual as a subject for
protection. Therefore, in Germany where
frozen storage of human embryo is prohibited,
only fertilized eggs before nuclear fusion are
considered to be subjects for procedures of
researches including the freezing procedure.
However, in Germany, embryo transplant, etc.,
in the assisted reproductive medicine is
permitted. (Günther & Keller, 1991; Ichino-
kawa, 1994; Suzumori, 2002, p. 19.)
* 14 Review of research subject
In order to conduct a peer review (review by
specialists) of the research subject, 44 peer
reviewers were registered at HFEA, and the
purpose of the research subject, the potential
importance, the justification for use of human
embryo, the validity of the experimental plan,
the suitability of the duration, and the
suitability of the qualification of the
applicants are judged. The results of the
review are shown to the applicant, and the
application is revised to increase clarity and
sent for license review by the HFEA commit-
tee.
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